Published in Pharma Investments, Ventures and Law Weekly, July 17th, 2005
The patent teaches the placement of an electronic sensor within medical devices that can offset the image artifacts that interfere with the quality of MRI imaging.
The new patent supports Biophan's strategy of aggressive expansion of its intellectual property portfolio with proprietary solutions covering opportunities across several multi-billion-dollar segments of the healthcare and biomedical device marketplace.
The company's intellectual property portfolio currently comprises 127 U.S. issued or pending patents and 46...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly